• DOI:10.5639/GABIJ.2012.0102.021
• Corpus ID: 73200163

Generics substitution in primary care: summary of the Dutch community pharmacies guidelines

@article{Grandia2012GenericsSI,
  title={Generics substitution in primary care: summary of the Dutch community pharmacies guidelines},
  author={L. Grandia},
  journal={Generics and Biosimilars Initiative journal},
  year={2012},
  volume={1},
  pages={102-103}
}

• L. Grandia
• Published 15 May 2012
• Medicine, Political Science
• Generics and Biosimilars Initiative journal

Background The latest version of the guidelines was prompted by a renewed interest in generics substitution. The fi rst edition of the guidelines was published following the introduction, in 1988, of a fi nancial rule for pharmacists that offered them a fee of one-third of the price difference between a generic and a brand-name drug per substitution. This rule changed many times thereafter, but in year 2000 the interest in substitution rose again, partly for fi nancial reasons and partly because ‘prescribing on generics name’ had been introduced. An updated version of the guidelines was deemed important for pharmacists as an instrument to weigh out the risks and benefi ts of substitution based on patient safety.